Checking liver health with a new device
Part of Digestive system clinical trials.
This study tests a new device called Hepatoscope that measures your liver health without a needle. It may be a good option if you have liver problems, diabetes, or metabolic syndrome and want a simple, noninvasive check.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have high liver enzymes, type 2 diabetes, or signs of metabolic syndrome
- You agree to take part in the study after learning about it
- You do not have a pacemaker or other active implanted device
- No wounds or cuts on the skin where the probe will be placed
- You are not pregnant or breastfeeding
- You are not in prison or under legal guardianship
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at non-invasive tests (tests that don’t require surgery) to see whether they can diagnose and predict how chronic liver disease will worsen over time. If you may have chronic liver disease, these tests could help doctors follow your condition more accurately.
This study looks at how well noninvasive tests (tests that don’t require surgery, like scans and blood-based measurements) can diagnose chronic liver disease in people with certain liver conditions. It may help doctors choose better, less invasive ways to identify the type and stage of liver problems.
This trial looks for better ways to detect liver scarring (fibrosis) in people with long-term liver disease. It may help find problems earlier.
This study is testing a new way to use a FibroScan (a non-invasive liver scanner) with a single probe to measure liver health in people with chronic liver disease. If you have a long-term liver condition, this trial may help improve how liver exams are done.
This study tests a new device called LiverScope® that scans your liver to detect fatty liver disease (MASLD). The scan uses special imaging technology and may help doctors diagnose liver disease more quickly and accurately.
This study tests a digital (computer/phone-based) system to help track people with higher risk of liver cancer so cancers can be found earlier. It may help by guiding regular check-ins and making early diagnosis more efficient.
Hear when a new Chronic Liver Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.